IRIS
BENVENGA, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 28.160
NA - Nord America 25.410
AS - Asia 16.355
SA - Sud America 6.297
AF - Africa 558
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 32
AN - Antartide 1
Totale 76.852
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.989
RU - Federazione Russa 13.651
SG - Singapore 7.573
BR - Brasile 5.471
CN - Cina 4.310
IE - Irlanda 3.595
SE - Svezia 2.478
IT - Italia 1.818
HK - Hong Kong 1.755
UA - Ucraina 1.587
DE - Germania 1.555
FR - Francia 1.017
VN - Vietnam 874
FI - Finlandia 780
GB - Regno Unito 583
PL - Polonia 484
IN - India 364
AR - Argentina 302
BD - Bangladesh 196
TR - Turchia 186
CA - Canada 183
IQ - Iraq 171
EC - Ecuador 158
MX - Messico 147
ZA - Sudafrica 128
ID - Indonesia 106
CO - Colombia 104
PK - Pakistan 99
NL - Olanda 98
MA - Marocco 97
IR - Iran 94
JP - Giappone 92
VE - Venezuela 81
BE - Belgio 75
ES - Italia 75
UZ - Uzbekistan 74
AT - Austria 72
CI - Costa d'Avorio 72
EG - Egitto 58
CZ - Repubblica Ceca 55
KE - Kenya 51
TN - Tunisia 51
PY - Paraguay 47
CL - Cile 42
AE - Emirati Arabi Uniti 39
AZ - Azerbaigian 39
PH - Filippine 38
DZ - Algeria 36
SA - Arabia Saudita 36
UY - Uruguay 36
PE - Perù 33
KZ - Kazakistan 31
AL - Albania 30
AU - Australia 30
CH - Svizzera 30
JO - Giordania 30
JM - Giamaica 28
LT - Lituania 25
KG - Kirghizistan 24
IL - Israele 21
NP - Nepal 21
BO - Bolivia 20
DO - Repubblica Dominicana 20
OM - Oman 19
EU - Europa 18
LB - Libano 18
PS - Palestinian Territory 17
RO - Romania 16
SN - Senegal 16
BG - Bulgaria 14
BH - Bahrain 14
DK - Danimarca 14
MY - Malesia 13
SY - Repubblica araba siriana 13
TW - Taiwan 13
GR - Grecia 12
RS - Serbia 12
NG - Nigeria 11
XK - ???statistics.table.value.countryCode.XK??? 11
BN - Brunei Darussalam 10
BY - Bielorussia 10
HN - Honduras 10
HU - Ungheria 10
PT - Portogallo 10
QA - Qatar 10
GE - Georgia 9
KR - Corea 9
PA - Panama 9
AO - Angola 8
BA - Bosnia-Erzegovina 8
CR - Costa Rica 8
ET - Etiopia 8
LV - Lettonia 7
NZ - Nuova Zelanda 7
AM - Armenia 6
MD - Moldavia 6
NI - Nicaragua 6
SK - Slovacchia (Repubblica Slovacca) 6
TH - Thailandia 6
EE - Estonia 5
Totale 76.764
Salva come PNG Salva come JPEG
Città #
Moscow 4.511
Singapore 3.649
Dublin 3.585
Jacksonville 3.352
Ashburn 3.107
Chandler 2.595
Dallas 2.334
Hong Kong 1.746
Beijing 1.337
Nyköping 1.269
San Jose 850
The Dalles 821
Dearborn 767
Princeton 763
Lauterbourg 675
Cambridge 674
Los Angeles 605
Des Moines 580
Warsaw 463
Medford 448
São Paulo 386
Ann Arbor 345
Council Bluffs 342
Buffalo 324
New York 287
Messina 280
Ho Chi Minh City 277
Boardman 268
Munich 236
Wilmington 221
Tianjin 216
Jinan 209
Redondo Beach 187
Guangzhou 176
Rio de Janeiro 165
Hanoi 163
Shenyang 146
Woodbridge 145
Nanjing 142
San Mateo 133
Belo Horizonte 131
Lancaster 114
Milan 112
Frankfurt am Main 107
Dong Ket 96
Rome 95
Orem 94
Houston 90
Pune 89
Seattle 88
Turku 86
Brasília 83
Santa Clara 83
Curitiba 82
Zhengzhou 82
Tokyo 79
Porto Alegre 75
Bremen 74
Brussels 74
Abidjan 71
Hebei 71
Haikou 70
Falls Church 69
Ningbo 69
Chennai 66
Shenzhen 66
Tashkent 66
Campinas 61
Taizhou 61
Guayaquil 60
Baghdad 59
Goiânia 59
Hangzhou 59
San Francisco 59
Stockholm 58
Johannesburg 57
Ribeirão Preto 57
Shanghai 57
Guarulhos 55
Montreal 54
Salvador 54
Catania 53
Nanchang 53
Nuremberg 51
Hyderabad 50
Quito 48
Brooklyn 47
Chicago 47
Helsinki 47
Nairobi 47
London 46
Boston 45
Tehran 44
Jiaxing 43
Norwalk 42
Brno 41
Fuzhou 41
Dhaka 40
Denver 39
Baku 38
Totale 42.733
Salva come PNG Salva come JPEG
Nome #
I LIVELLI SIERICI DI INTERLEUCHINA 23 (IL-23) SONO AUMENTATI NEI PAZIENTI CON TIROIDITE DI HASHIMOTO (TH) DI NUOVA DIAGNOSI RISPETTO AI CONTROLLI SANI 722
131I RADIOIODINE THERAPY (RIT) OF HYPERTYROIDISM DUE TO GRAVES’ DISEASE (GD) OR UNI-MULTINODULAR TOXIC GOITER (NTG): OUR EXPERIENCE 256
131I Radioiodine therapy (RIT) of hyperthyroidism due to Graves' disease (GD) or uni-multinodular toxic goiter (NTG): our experience 245
Differente frequenza di Tiroidite Cronica Linfocitaria (TCL) diagnosticata mediante agoaspirato di noduli tiroidei in due province della Sicilia Orientale: possibile ruolo dell’inquinamento ambientale 242
Refractoriness of two novel formulations of L-T4 (oral solution and soft gel capsule) to the coffee-induced intestinal absorption of tablet L-T4. 234
Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity 233
Annual increase in the frequency of papillary thyroid carcinoma as diagnosed by fine-needle aspiration at a cytology unit in Sicily. 230
Prospective study on the triggering role of stress in Graves' disease. 226
Loss of heterozygosity on 7q21.1-7q31.3 is distinctive of the follicular thyroid neoplasms. 225
3 NEW MUTATIONS OF THYROID-HORMONE RECEPTOR-BETA ASSOCIATED WITH RESISTANCE TO THYROID-HORMONE 221
Coffee impairs intestinal absoprtion of levo-thyroxine: report of additional cases. 219
A minimum of two years of undertreated primary hypothyroidism, as a result of drug-induced malabsorption of L-thyroxine, may have metabolic and cardiovascular consequences 217
Studio prospettico sul ruolo degli eventi stressanti (ES nello scatenamento degli episodi di ipertiroidismo da morbo di Basedow (MB). 215
Personalization of targeted therapy in advanced thyroid cancer. 211
I livelli sierici di interleuchina 22 (IL-22) sono aumentati nella tiroidite di Hashimoto rispetto alle tireopatie non autoimmuni ed ai controlli sani. 208
Myo-inositol and melatonin in the menopausal transition 205
A patient with stress-related onset and exacerbations of Graves disease. 203
Assessment of serum thyroid hormone autoantibodies in the first trimester of gestation as predictors of postpartum thyroiditis 203
A novel formulation of L-thyroxine (L-T4) solves problems of L-T4 malabsorption caused by coffee in patients under replacement or TSH suppressive L-T4 therapy with conventional tablets. 200
Autoimmune Abnormalities of Postpartum Thyroid Diseases 199
Favorable effects of myo-inositol, selenomethionine or their combination on the hydrogen peroxide-induced oxidative stress of peripheral mononuclear cells from patients with Hashimoto's thyroiditis: preliminary in vitro studies 198
Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? 197
Livelli di TSH e parametri metabolici in soggetti eutiroidei con diabete di tipo 2 196
A case of clinically silent acromegaly with erectile dysfunction. 196
Alexithymia, Emotional Distress, and Perceived Quality of Life in Patients With Hashimoto's Thyroiditis 196
A case of Graves' disease (GD) triggered by immunotherapy with the tumor-associated antigen NY-ESO-1. 195
Coffee Impairs Intestinal Absorbtion of Levothyroxine: Report of Additional Cases 193
A liquid formulation of L-thyroxine (L-T4) solves problems of incomplete normalization/suppression of serum TSH caused by proton pump inhibitors (PPI) on conventional tablet formulations of L-T4. 193
High frequency of empty sella, with gender differences, in the early neuroradiology evaluation of patients with traumatic brain injury. A prospective study. 192
Immunoreactions for P53 isoforms are associated with ultrastructural proliferative profiles in benign thyroid nodules 191
Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study 191
Association of autonously functioning ("hot") thyroid nodules with Hashimotos' thyroiditis (HT). 190
A novel formulation of l-thyroxine (l-T4) reduces the problem of l-T4 malabsorption by coffee observed with traditional tablet formulations 190
Biochemical features of eugonadal patients with idiopathic gynaecomastia: A retrospective cross-sectional study 188
Increased annual frequency of Hashimoto's thyroiditis between years 1988 and 2007 at a cytological unit of Sicily. 187
Influence of peroxisome proliferator-activated receptor-γ exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome 187
Interference of L-T4 absorption by proton-pump inhibitors (PPIs) can be solved by a liquid ormulation of L-thyroxine (L-T4). 185
Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions 184
Allelic loss at 7q21 is a frequent and early event in thyroid follicular tumors. 184
THYROID HORMONE TRANSPORT PROTEINS AND THE PHYSIOLOGY OF HORMONE BINDING. 184
Hyponatremia as a leading sign of hypopituitarism 184
Autoimmunity to heterogeneous nuclear ribonucleoprotein A1 in psoriatic patients and correlation with disease severity 183
Rates of lymphocytic thyroiditis and ultrasound features of citologically-interrogated thyroid nodules based on the area of residence in a Sicily province 182
Un caso di orticaria cronica idiopatica (OCI) associata a morbo di Basedow (MB): tipizzazione HLA. 180
The micropapillary/hobnail variant of papillary thyroid carcinoma: A review of series described in the literature compared to a series from one southern Italy pathology institution 179
Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor 178
Analisi immunoistochimica dei "pathways" del sistema HGF/c-met in noduli tiroidei benigni e maligni. 178
Effetti favorevoli di Selenometionina (SM), Mioinositolo (MI) oppure SM+MI su linfociti periferici (LP) sotto stress ossidativo (SOSS) in donne con T. di Hashimoto (TH): studi preliminari in vitro 177
Analisi immunoistochimica dell'espressione dlel'epidermal growth factor receptor (EGFR) e di HER2 nel carcinoma midollare della tiroide (MCT). 176
A patient-specific treatment model for Graves' hyperthyroidism 174
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 173
Beneficial effects of oral pure caffeine on oxidative stress 173
Comment to ‘glucocorticoid resistance syndrome caused by a novel nr3c1 point mutation’ by al argan et al. 173
Circulating thyrotropin is upregulated by estradiol 173
A quantitative assessment of depression and thyroid dysfunction secondary to interferon-alpha therapy in patients with hepatitis C 171
Additional cases of impairment of L-thyroxine (L-T4) intestinal absorption caused by coffee. 171
Association of primary hyperparathyoidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service. 170
Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism 170
Very High Frequency of the Polymorphism for the Insulin Receptor Substrate 1 (IRS-1) at Codon 972 (Glycine972Arginine) in Southern Italian Women with Polycystic Ovary Syndrome. 169
Association of Lichen sclerosus and autoimmune thyroiditis: Possible role of Borrelia burgdorferi? 168
Aplotipi del microsatellite D7S6440, localizzato nell'introne 9 del gene HIPK2, come marcatori molecolari della tiroidite di Hashimoto 168
Cortical excitability in patients with resistance to thyroid hormone compared to patients with hypothyroidism and euthyroid controls: a transcranial magnetic stimulation study 168
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG) 167
Autoimmune thyroiditis and glomerulopathies 166
Apoptosis and apoptosis-related proteins in thyroid myopathies 165
Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules 164
Association of autonomously functioning thyroid nodules (AFTNs) with Hashimoto's thyroiditis (HT) 164
A case of L-T4 malabsorption caused by a proton pump inhibitor and solved by a novel formulation of L-T4. 164
A QUICK METHOD TO DETECT CIRCULATING ANTITHYROID HORMONE AUTOANTIBODIES 163
Alessitimia (AT) e depressione postpartum (DPP): correlazione con TSH, ormoni tiroidei (OT) ed autoanticorpi tiroidei (ABT). 163
Amino acid sequence homology between thyroid autoantigens and central nervous system proteins: Implications for the steroid-responsive encephalopathy associated with autoimmune thyroiditis 163
Association between primary hyperprathyroidism (p-hyperPTH) and nodular toxic goiter (NTG): a prospective study at an outpatient service for osteoporosis 162
Additional evidence that the fibril amyloid-related proteins share local regions of amino acid sequence similarity. 162
Thyroid hormone autoantibodies: Are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments? 162
Myo-inositol in the protection from cadmium-induced toxicity in mice kidney: An emerging nutraceutical challenge 162
Gly972Arg of IRS-1 and Lys121Gln of PC-1 polymorphisms act in opposite way in polycystic ovary syndrome 162
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 161
Pattern of nodal involvement in papillary thyroid cancer: a challenge of quantitative analysis 161
Drug interactions with levothyroxine therapy in patients with hypothyroidism: observational study in general practice 161
Marked improvement of thyroid function and autoimmunity by Aloe barbadensis miller juice in patients with subclinical hypothyroidism 161
Abnormal daily periodicity of serum thyrotropin (TSH) and evidencefor defective TSH suppression in a case of non-neoplastic syndrome ofinappropriate TSH secretion. 160
Thyroid Gland: Anatomy and Physiology 160
ATYPICAL PRESENTATION OF PARATHYROID CARCINOMA (PC): REPORT OF TWO CASES 159
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes 159
One-third of an archivial series of papillary thyroid cancer (Years 2007-2015) has coexistent chronic lymphocytic thyroiditis, which is associated with a more favorable Tumor-node-metastasis staging 159
Thyroid metastases from renal cell carcinoma: review of the literature. 157
BRAF status in papillary microcarcinomas of the thyroid gland: A brief review 157
Looking for Increased Prevalence of Hashimoto's Thyroiditis (HT)in Patients with Sarcoidosis (SAR)and Finding an Increased Rate of High Serum Levels of Thyroxine-binding Globulin (TBG)with Presumably Impaired Binding Property. 156
ASSOCIATION OF PRIMARY HYPERPARATHYROIDISM (P-HYPERPTH) WITH NODULAR TOXIC GOITER (NTG): A PROSPECTIVE STUDY AT AN OUTPATIENT OSTEOPOROSIS SERVICE 156
Expressions of Δ 133 isoforms of P53 in multinodular thyroids: the immunoreactions in benign lesions are correlating with subcellular phenotypes of electron microscopy 155
Vitamin D receptor polymorphism in chronic kidney disease patients with complicated cardiovascular disease 155
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 155
Iodine-131 treatment of hyperthyroidism: our experience 154
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease 154
Cell-specific loss of heterozygosity (LOH) on chromosome 7q21 in thyroid tumors: analysis on 267 laser capture microdissected thyroid lesions 153
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service 153
Antithyroid medications and psychosis 153
Myo-inositol and selenium reduce the risk of developing overt hypothyroidism in patients with autoimmune thyroiditis 153
Preoperatively undiagnosed papillary thyroid carcinoma in patients thyroidectomized for benign multinodular goiter 153
L-carnitine (CAR) affects locomotor activity (LMA) in homozygous transgenic mice that express the Q340H mutated human TRbeta-1 protein, a mutation associated with both thyroid hormone resistance (RTH) and attention deficit/hyperactivity disorder (ADHD). 152
Totale 18.615
Salva come PNG Salva come JPEG
Categoria #
all - tutte 264.501
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 264.501
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021226 0 0 0 0 0 0 0 0 0 0 0 226
2021/20224.013 38 414 71 180 214 63 284 206 95 449 636 1.363
2022/202310.394 945 677 357 822 819 987 97 622 4.473 54 397 144
2023/20242.538 252 421 215 237 210 478 42 169 10 109 60 335
2024/202513.906 219 181 273 666 694 320 216 3.231 3.500 680 1.321 2.605
2025/202633.043 1.412 2.319 2.687 2.553 2.534 7.735 4.307 3.878 3.674 1.332 603 9
Totale 77.838